Acasti Pharma | ACST - Cost Of Sales

Stock Price
4.38
Daily Change
-0.06 -1.35%
Monthly
12.89%
Yearly
71.09%
Q1 Forecast
4.10

Acasti Pharma reported $0 in Cost of Sales for its fiscal quarter ending in March of 2022.





Cost Of Sales Change Date
Addus HomeCare USD 253.62M 3.63M Dec/2025
Amarin USD 26.05M 1.41M Dec/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Option Care Health USD 1.2B 23.4M Dec/2025
Organigram Holdings CAD 56.93M 20.53M Dec/2025
Tilray USD 164.37M 8.41M Sep/2025